home > drugs a-z list > pylera capsules (bismuth subcitrate potassium) drug center > pylera capsules (bismuth subcitrate potassium) drug - overdosage and contraindications

In case of an overdose, patients should contact a physician, poison control center, or emergency room. There is neither a pharmacological basis nor data suggesting an increased toxicity of the combination compared to individual components.

PYLERA™ therapy is contraindicated in pregnant or nursing women, pediatric patients, in patients with renal or hepatic impairment, and in those with known hypersensitivity to bismuth subcitrate potassium, metronidazole or other nitroimidazole derivatives, or tetracyclines. (See WARNINGS and PRECAUTIONS)

Last reviewed on RxList: 6/13/2007
This monograph has been modified to include the generic and brand name in many instances.